» Articles » PMID: 33653314

The Association Between Eosinophilic Exacerbation and Eosinophilic Levels in Stable COPD

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2021 Mar 3
PMID 33653314
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Blood eosinophil count may predict treatment response in patients with chronic obstructive pulmonary disease (COPD) during acute exacerbations (AE). However, the ability and thresholds of blood eosinophil counts in stable status to predict eosinophilic AECOPD have not been completely investigated.

Methods: This was a retrospective multicenter study performed January 2010 to December 2014. COPD subjects hospitalized with exacerbations, were included. Blood samples were obtained at the time of AE and stable disease at outpatient clinic before or after admission. We identified a blood eosinophil count cut-off point at stable COPD, either taken as a percentage or as absolute value, for identification of eosinophilic exacerbation.

Results: There was significant positive correlation of eosinophil counts between stable COPD and AECOPD. The best cut-off value of blood eosinophil count in stable status for the prediction of eosinophilic COPD exacerbation based on blood eosinophil count ≥ 2% was 300 cells/µL (area under the ROC curve [AUC] 0.614, P = 0.001, 39% sensitivity, 83.8% specificity). When the eosinophilic COPD exacerbation was based on blood eosinophil count ≥ 300 cells/µL, the best cut-off value of blood eosinophil count in stable status for the prediction of eosinophilic COPD exacerbation was also 300 cells/uL (AUC 0.634, P = 0.046, 45.8% sensitivity, 80.9% specificity).

Conclusions: We demonstrated association between blood eosinophil counts at stable COPD and those with AECOPD. The thresholds of blood counts at stable COPD to predict eosinophilic exacerbations was 300 cells/µL. Further and prospective studies in other populations should validate our results.

Citing Articles

Impact of blood eosinophil count on clinical outcomes in hospitalized Syrian patients with COPD exacerbation.

Albuaini S, Najjar M, Tulaiba D, Al Bardan H J Int Med Res. 2024; 52(11):3000605241299943.

PMID: 39610311 PMC: 11605759. DOI: 10.1177/03000605241299943.


Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation.

Chen T, Lee K, Chang J, Chung C, Tran H, Manullang A Ann Med. 2023; 55(2):2285924.

PMID: 38065676 PMC: 10836240. DOI: 10.1080/07853890.2023.2285924.


COPD Exacerbation Syndrome: The Spanish Perspective on an Old Dilemma.

Soler-Cataluna J, Lopez-Campos J Int J Chron Obstruct Pulmon Dis. 2023; 17:3139-3149.

PMID: 36601561 PMC: 9807017. DOI: 10.2147/COPD.S393535.


Using inflammatory index to distinguish asthma, asthma-COPD overlap and COPD: A retrospective observational study.

Ma H, Yang L, Liu L, Zhou Y, Guo X, Wu S Front Med (Lausanne). 2022; 9:1045503.

PMID: 36465915 PMC: 9714673. DOI: 10.3389/fmed.2022.1045503.


Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?.

Cen L, Zhang X, Guan W ERJ Open Res. 2021; 7(3).

PMID: 34350289 PMC: 8326715. DOI: 10.1183/23120541.00362-2021.


References
1.
Schumann D, Tamm M, Kostikas K, Stolz D . Stability of the Blood Eosinophilic Phenotype in Stable and Exacerbated COPD. Chest. 2019; 156(3):456-465. DOI: 10.1016/j.chest.2019.04.012. View

2.
Singh D, Kolsum U, Brightling C, Locantore N, Agusti A, Tal-Singer R . Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014; 44(6):1697-700. DOI: 10.1183/09031936.00162414. View

3.
Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P . Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012; 186(1):48-55. PMC: 3400995. DOI: 10.1164/rccm.201108-1553OC. View

4.
Kerkhof M, Sonnappa S, Postma D, Brusselle G, Agusti A, Anzueto A . Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017; 50(1). DOI: 10.1183/13993003.00761-2017. View

5.
Negewo N, McDonald V, Baines K, Wark P, Simpson J, Jones P . Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:1495-504. PMC: 4936821. DOI: 10.2147/COPD.S100338. View